Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New combo inhaler aims to ease asthma symptoms

NCT ID NCT06664619

Disease control Sponsor: Teva Branded Pharmaceutical Products R&D LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 01, 2026 · Updated 2 times

Summary

This phase 3 trial tests a new inhaler that combines fluticasone (an anti-inflammatory) and albuterol (a fast-acting bronchodilator) for people 12 and older with asthma. Over 4 weeks, researchers will measure lung function and safety in 724 participants. The goal is to see if the combination works better than each drug alone or a placebo.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
fluticasone propionate and albuterol sulfate combination inhaler
What this could lead to
If successful, this could offer a more convenient and effective daily inhaler for managing asthma symptoms.
What could go wrong
This is a short, 4-week trial focused on lung function, not long-term outcomes. The combination may not prove significantly better than existing treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 724 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2024

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The participant has a diagnosis of asthma of at least 6 months duration. * Participants currently receive a beta-agonist (eg, salbutamol \[albuterol\] or ICS albuterol or ICS-formoterol) as rescue medication with or without asthma controller medication. * If female, a participant is currently not pregnant, breastfeeding, or attempting to become pregnant (for at least 30 days before the screening visit and throughout the duration of the trial), or is of non-childbearing potential. NOTE- Additional criteria apply, please contact the investigator for more information Exclusion Criteria: * The participant has a history of life-threatening asthma defined as any history of significant asthma episode(s) requiring intubation, associated with hypercapnia, respiratory arrest, hypoxic seizures or an asthma related syncopal episode. * The participant has had an upper or lower respiratory tract infection within 2 weeks or has had a confirmed case of COVID-19 within 6 weeks prior to Visit 1. Symptoms of the infection(s) must be completely resolved prior to entering screening. * The participant is a current smoker and/or has a history of ≥10 pack years history of smoking. A current smoker is defined as any participant who has used any form of tobacco product (including oral) within the past 6 months, or any orally inhaled products including but not limited to cigarettes, beedis, vaping/ e-cigarettes, hookah/waterpipes, or marijuana. Note: participants with a positive urinary cotinine test will be excluded. * The participant has another confounding underlying lung disorder (eg, chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, bronchiectasis with the need of treatment, cystic fibrosis, pulmonary fibrosis), or participants with a diagnosis of asthma COPD overlap syndrome. NOTE- Additional criteria apply, please contact the investigator for more information

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Asthma

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    125 sites in 11 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Teva Investigational Site 12060

    RECRUITING

    Austin, Texas, 78759, United States

  • Teva Investigational Site 12061

    COMPLETED

    Miami, Florida, 33174, United States

  • Teva Investigational Site 12062

    RECRUITING

    Greenfield, Wisconsin, 53228, United States

  • Teva Investigational Site 12063

    COMPLETED

    Toledo, Ohio, 43617, United States

  • Teva Investigational Site 12064

    RECRUITING

    San Jose, California, 95117, United States

  • Teva Investigational Site 12066

    COMPLETED

    Richfield, Minnesota, 55423, United States

  • Teva Investigational Site 12067

    COMPLETED

    Columbia, South Carolina, 29204, United States

  • Teva Investigational Site 12068

    RECRUITING

    La Palma, California, 90623, United States

  • Teva Investigational Site 12070

    COMPLETED

    Vista, California, 92083, United States

  • Teva Investigational Site 12071

    RECRUITING

    Miami, Florida, 33126, United States

  • Teva Investigational Site 12072

    RECRUITING

    Philadelphia, Pennsylvania, 19107, United States

  • Teva Investigational Site 12073

    COMPLETED

    Minneapolis, Minnesota, 55402-2606, United States

  • Teva Investigational Site 12074

    RECRUITING

    Miami, Florida, 33135, United States

  • Teva Investigational Site 12075

    RECRUITING

    Pompano Beach, Florida, 33064, United States

  • Teva Investigational Site 12076

    COMPLETED

    North Miami Beach, Florida, 33169, United States

  • Teva Investigational Site 12077

    COMPLETED

    Corsicana, Texas, 75110-2471, United States

  • Teva Investigational Site 12078

    RECRUITING

    Tampa, Florida, 33607, United States

  • Teva Investigational Site 12079

    RECRUITING

    Melbourne, Florida, 32934, United States

  • Teva Investigational Site 12080

    COMPLETED

    Kingwood, Texas, 77339, United States

  • Teva Investigational Site 12081

    COMPLETED

    Nottingham, Maryland, 21236, United States

  • Teva Investigational Site 12082

    COMPLETED

    Salt Lake City, Utah, 84123, United States

  • Teva Investigational Site 12083

    RECRUITING

    Austin, Texas, 78744, United States

  • Teva Investigational Site 12084

    RECRUITING

    Victoria, Texas, 77901, United States

  • Teva Investigational Site 12085

    RECRUITING

    Raleigh, North Carolina, 27607-6689, United States

  • Teva Investigational Site 12086

    RECRUITING

    Miami, Florida, 33173, United States

  • Teva Investigational Site 12087

    RECRUITING

    Phoenix, Arizona, 85015, United States

  • Teva Investigational Site 12088

    RECRUITING

    Los Angeles, California, 90048, United States

  • Teva Investigational Site 12089

    RECRUITING

    St Louis, Missouri, 63141, United States

  • Teva Investigational Site 12090

    RECRUITING

    Dallas, Texas, 75243, United States

  • Teva Investigational Site 12091

    COMPLETED

    Walnut Creek, California, 94598, United States

  • Teva Investigational Site 12092

    COMPLETED

    Miami Lakes, Florida, 33014, United States

  • Teva Investigational Site 12093

    COMPLETED

    Portsmouth, Virginia, 23703, United States

  • Teva Investigational Site 12094

    RECRUITING

    Los Angeles, California, 93551, United States

  • Teva Investigational Site 12095

    COMPLETED

    Palmetto Bay, Florida, 33157, United States

  • Teva Investigational Site 12096

    RECRUITING

    McKinney, Texas, 75069, United States

  • Teva Investigational Site 12097

    RECRUITING

    Miami, Florida, 33175, United States

  • Teva Investigational Site 12098

    COMPLETED

    Lake City, Florida, 32055-4880, United States

  • Teva Investigational Site 12101

    COMPLETED

    Sacramento, California, 95821, United States

  • Teva Investigational Site 12102

    RECRUITING

    Little Rock, Arkansas, 72205, United States

  • Teva Investigational Site 12103

    RECRUITING

    Huntington Beach, California, 92647, United States

  • Teva Investigational Site 12104

    COMPLETED

    Tucson, Arizona, 85715, United States

  • Teva Investigational Site 12105

    RECRUITING

    Oxnard, California, 93030-5822, United States

  • Teva Investigational Site 12106

    RECRUITING

    Towson, Maryland, 21204, United States

  • Teva Investigational Site 12107

    RECRUITING

    Rock Hill, South Carolina, 29732, United States

  • Teva Investigational Site 12108

    RECRUITING

    St Louis, Missouri, 63110, United States

  • Teva Investigational Site 12109

    COMPLETED

    Upland, California, 91786, United States

  • Teva Investigational Site 12110

    RECRUITING

    Jersey City, New Jersey, 07306, United States

  • Teva Investigational Site 12111

    COMPLETED

    Myrtle Beach, South Carolina, 29572, United States

  • Teva Investigational Site 12112

    COMPLETED

    North Charleston, South Carolina, 29420, United States

  • Teva Investigational Site 12113

    RECRUITING

    Mesquite, Texas, 75150, United States

  • Teva Investigational Site 12114

    RECRUITING

    Pittsburgh, Pennsylvania, 15241, United States

  • Teva Investigational Site 12115

    RECRUITING

    Charlotte, North Carolina, 28207, United States

  • Teva Investigational Site 12117

    COMPLETED

    Clackamas, Oregon, 97015, United States

  • Teva Investigational Site 12118

    COMPLETED

    Lake Worth, Florida, 33460-4400, United States

  • Teva Investigational Site 12119

    RECRUITING

    Boston, Massachusetts, 02115, United States

  • Teva Investigational Site 12142

    RECRUITING

    Lakewood, Colorado, 80228, United States

  • Teva Investigational Site 12143

    RECRUITING

    El Paso, Texas, 79912, United States

  • Teva Investigational Site 12144

    COMPLETED

    Phoenix, Arizona, 85020, United States

  • Teva Investigational Site 12145

    RECRUITING

    Long Beach, California, 90815, United States

  • Teva Investigational Site 12146

    RECRUITING

    Tucson, Arizona, 85741, United States

  • Teva Investigational Site 12147

    COMPLETED

    Horsham, Pennsylvania, 19044, United States

  • Teva Investigational Site 12148

    RECRUITING

    Pleasant View, Utah, 84404-4791, United States

  • Teva Investigational Site 12149

    RECRUITING

    Columbia, Missouri, 65203, United States

  • Teva Investigational Site 12150

    RECRUITING

    Las Vegas, Nevada, 89119, United States

  • Teva Investigational Site 12151

    COMPLETED

    Portland, Oregon, 97202, United States

  • Teva Investigational Site 12152

    RECRUITING

    Laguna Niguel, California, 92677, United States

  • Teva Investigational Site 12153

    RECRUITING

    South Ogden, Utah, 84405, United States

  • Teva Investigational Site 12154

    RECRUITING

    Encinitas, California, 92024-2812, United States

  • Teva Investigational Site 12155

    RECRUITING

    Tulsa, Oklahoma, 74133, United States

  • Teva Investigational Site 12156

    RECRUITING

    Boise, Idaho, 83706, United States

  • Teva Investigational Site 12157

    RECRUITING

    White Marsh, Maryland, 21162-5503, United States

  • Teva Investigational Site 12158

    RECRUITING

    Hastings, Nebraska, 68901, United States

  • Teva Investigational Site 12159

    RECRUITING

    Dallas, Texas, 75225-6301, United States

  • Teva Investigational Site 12160

    RECRUITING

    Las Vegas, Nevada, 89113, United States

  • Teva Investigational Site 12161

    RECRUITING

    Northridge, California, 91324, United States

  • Teva Investigational Site 12162

    RECRUITING

    Westchester, Illinois, 60154, United States

  • Teva Investigational Site 12166

    RECRUITING

    Sugar Land, Texas, 77479, United States

  • Teva Investigational Site 12168

    RECRUITING

    Houston, Texas, 77018, United States

  • Teva Investigational Site 12169

    RECRUITING

    Shreveport, Louisiana, 71105, United States

  • Teva Investigational Site 12170

    RECRUITING

    Tulsa, Oklahoma, 74136, United States

  • Teva Investigational Site 12171

    RECRUITING

    Dallas, Texas, 75235, United States

  • Teva Investigational Site 12175

    RECRUITING

    Conyers, Georgia, 30012, United States

  • Teva Investigational Site 12176

    RECRUITING

    Kerrville, Texas, 78028, United States

  • Teva Investigational Site 12178

    RECRUITING

    Oklahoma City, Oklahoma, 73120, United States

  • Teva Investigational Site 12179

    RECRUITING

    Cypress, Texas, 77429, United States

  • Teva Investigational Site 12181

    RECRUITING

    Houston, Texas, 77008-1528, United States

  • Teva Investigational Site 12182

    RECRUITING

    South Dartmouth, Massachusetts, 02747, United States

  • Teva Investigational Site 12183

    RECRUITING

    Tomball, Texas, 77081, United States

  • Teva Investigational Site 12184

    RECRUITING

    Houston, Texas, 77065, United States

  • Teva Investigational Site 12185

    RECRUITING

    High Point, North Carolina, 27260, United States

  • Teva Investigational Site 12187

    RECRUITING

    Brighton, Michigan, 48116, United States

  • Teva Investigational Site 20145

    RECRUITING

    Mar del Plata, 7600, Argentina

  • Teva Investigational Site 20146

    COMPLETED

    Quilmes, 1878, Argentina

  • Teva Investigational Site 20147

    RECRUITING

    San Juan Bautista, B1853AIK, Argentina

  • Teva Investigational Site 20148

    RECRUITING

    Rosario, 2013, Argentina

  • Teva Investigational Site 20149

    COMPLETED

    San Miguel de Tucumán, T4000IFL, Argentina

  • Teva Investigational Site 20150

    RECRUITING

    Córdoba, X5014AKM, Argentina

  • Teva Investigational Site 20151

    RECRUITING

    Mar del Plata, B7612ENA, Argentina

  • Teva Investigational Site 20152

    RECRUITING

    San Miguel de Tucumán, 4000, Argentina

  • Teva Investigational Site 20154

    RECRUITING

    Buenos Aires, C1426ABP, Argentina

  • Teva Investigational Site 20155

    RECRUITING

    Rosario, S2000DEJ, Argentina

  • Teva Investigational Site 20156

    RECRUITING

    Buenos Aires, S2013DTC, Argentina

  • Teva Investigational Site 20157

    RECRUITING

    Córdoba, X5003DCE, Argentina

  • Teva Investigational Site 20158

    RECRUITING

    Santa Fe, S3000ASF, Argentina

  • Teva Investigational Site 20159

    RECRUITING

    San Miguel de Tucumán, 4000, Argentina

  • Teva Investigational Site 20160

    RECRUITING

    Florida, B1602DQD, Argentina

  • Teva Investigational Site 20161

    RECRUITING

    Mendoza, 5500, Argentina

  • Teva Investigational Site 21133

    COMPLETED

    Chihuahua City, 31203, Mexico

  • Teva Investigational Site 21134

    RECRUITING

    Mexico City, 14090, Mexico

  • Teva Investigational Site 21135

    ACTIVE_NOT_RECRUITING

    Zapopan, 45138, Mexico

  • Teva Investigational Site 21136

    RECRUITING

    Tlalnepantla, 54055, Mexico

  • Teva Investigational Site 21137

    RECRUITING

    Morelia, 58260, Mexico

  • Teva Investigational Site 32876

    RECRUITING

    Leipzig, 04207, Germany

  • Teva Investigational Site 32877

    COMPLETED

    Magdeburg, 39120, Germany

  • Teva Investigational Site 32878

    RECRUITING

    Mainz, 55128, Germany

  • Teva Investigational Site 32879

    RECRUITING

    Frankfurt, 60596, Germany

  • Teva Investigational Site 32880

    COMPLETED

    Bendorf, 56170, Germany

  • Teva Investigational Site 32881

    COMPLETED

    Ahrensburg, 22926, Germany

  • Teva Investigational Site 32882

    RECRUITING

    Rheine, 48431, Germany

  • Teva Investigational Site 32883

    COMPLETED

    Leipzig, 04347, Germany

  • Teva Investigational Site 32884

    RECRUITING

    Berlin, 10717, Germany

  • Teva Investigational Site 32886

    RECRUITING

    Berlin, 10787, Germany

  • Teva Investigational Site 32887

    RECRUITING

    Leipzig, 04177, Germany

  • Teva Investigational Site 32888

    RECRUITING

    Neu-Isenburg, 63263, Germany

  • Teva Investigational Site 32889

    RECRUITING

    Witten, 58452, Germany

  • Teva Investigational Site 32890

    COMPLETED

    Peine, 31224, Germany

  • Teva Investigational Site 32892

    RECRUITING

    Frankfurt, 60596, Germany

  • Teva Investigational Site 32893

    RECRUITING

    Delitzsch, 04509, Germany

  • Teva Investigational Site 52145

    COMPLETED

    Timișoara, 2447, Romania

  • Teva Investigational Site 52147

    RECRUITING

    Oradea, 410169, Romania

  • Teva Investigational Site 52148

    COMPLETED

    Craiova, 410169, Romania

  • Teva Investigational Site 52149

    RECRUITING

    Bucharest, 077025, Romania

  • Teva Investigational Site 53574

    COMPLETED

    Tarnów, 70-332, Poland

  • Teva Investigational Site 53575

    COMPLETED

    Lodz, 90-127, Poland

  • Teva Investigational Site 53576

    COMPLETED

    Lodz, 95-002, Poland

  • Teva Investigational Site 53577

    RECRUITING

    Wroclaw, 50-381, Poland

  • Teva Investigational Site 53578

    COMPLETED

    Gdansk, 84-230, Poland

  • Teva Investigational Site 53579

    RECRUITING

    Poznan, 60-309, Poland

  • Teva Investigational Site 53580

    RECRUITING

    Bialystok, 15-430, Poland

  • Teva Investigational Site 53581

    RECRUITING

    Maków Podhalański, 34-220, Poland

  • Teva Investigational Site 53582

    COMPLETED

    Bialystok, 15-010, Poland

  • Teva Investigational Site 54243

    COMPLETED

    Varnsdorf, 40747, Czechia

  • Teva Investigational Site 54244

    COMPLETED

    Teplice, 41501, Czechia

  • Teva Investigational Site 54245

    COMPLETED

    Jindřichův Hradec, 37738, Czechia

  • Teva Investigational Site 54246

    RECRUITING

    Prague, 148 00, Czechia

  • Teva Investigational Site 54247

    RECRUITING

    Brandýs nad Labem, 25001, Czechia

  • Teva Investigational Site 54248

    RECRUITING

    Brno, 618 00, Czechia

  • Teva Investigational Site 54249

    RECRUITING

    Prague, 190 00, Czechia

  • Teva Investigational Site 59245

    COMPLETED

    Stara Zagora, 6000, Bulgaria

  • Teva Investigational Site 59246

    RECRUITING

    Sofia, 1142, Bulgaria

  • Teva Investigational Site 59247

    COMPLETED

    Pleven, 5800, Bulgaria

  • Teva Investigational Site 59248

    RECRUITING

    Haskovo, 6305, Bulgaria

  • Teva Investigational Site 59249

    RECRUITING

    Montana, 3400, Bulgaria

  • Teva Investigational Site 59250

    COMPLETED

    Vratsa, 3000, Bulgaria

  • Teva Investigational Site 59251

    COMPLETED

    Lovech, 5500, Bulgaria

  • Teva Investigational Site 59252

    COMPLETED

    Sofia, 1233, Bulgaria

  • Teva Investigational Site 59253

    COMPLETED

    Sofia, 5400, Bulgaria

  • Teva Investigational Site 59254

    COMPLETED

    Veliko Tarnovo, 5000, Bulgaria

  • Teva Investigational Site 59256

    COMPLETED

    Sliven, 8800, Bulgaria

  • Teva Investigational Site 59257

    ACTIVE_NOT_RECRUITING

    Sofia, 1421, Bulgaria

  • Teva Investigational Site 59258

    RECRUITING

    Montana, 3400, Bulgaria

  • Teva Investigational Site 59259

    COMPLETED

    Rousse, 7002, Bulgaria

  • Teva Investigational Site 61088

    RECRUITING

    Belgrade, 11080, Serbia

  • Teva Investigational Site 61089

    RECRUITING

    Belgrade, 11000, Serbia

  • Teva Investigational Site 61090

    RECRUITING

    Belgrade, 11000, Serbia

  • Teva Investigational Site 61091

    RECRUITING

    Užice, 501715, Serbia

  • Teva Investigational Site 61092

    RECRUITING

    Belgrade, 11070, Serbia

  • Teva Investigational Site 61093

    RECRUITING

    Belgrade, 11000, Serbia

  • Teva Investigational Site 61094

    RECRUITING

    Kragujevac, 34000, Serbia

  • Teva Investigational Site 61095

    RECRUITING

    Novi Sad, 21000, Serbia

  • Teva Investigational Site 61096

    RECRUITING

    Niš, 18 000, Serbia

  • Teva Investigational Site 62101

    COMPLETED

    Spišská Nová Ves, 05201, Slovakia

  • Teva Investigational Site 62102

    COMPLETED

    Košice, 04022, Slovakia

  • Teva Investigational Site 62103

    COMPLETED

    Martin, 03601, Slovakia

  • Teva Investigational Site 80206

    COMPLETED

    Haifa, 3109601, Israel

  • Teva Investigational Site 80207

    COMPLETED

    Be’er Ya‘aqov, 70300, Israel

  • Teva Investigational Site 80208

    RECRUITING

    Jerusalem, 91240, Israel

  • Teva Investigational Site 82085

    COMPLETED

    Kirikkale, 71450, Turkey (Türkiye)

  • Teva Investigational Site 82087

    COMPLETED

    Mersin, 33343, Turkey (Türkiye)

  • Teva Investigational Site 82088

    COMPLETED

    Kocaeli, 41140, Turkey (Türkiye)

  • Teva Investigational Site 82089

    COMPLETED

    Adana, 1330, Turkey (Türkiye)

  • Teva Investigational Site 90096

    RECRUITING

    Pietermaritzburg, 944, South Africa

  • Teva Investigational Site 90097

    RECRUITING

    Vhembe, 944, South Africa

  • Teva Investigational Site 90098

    RECRUITING

    Pretoria, 0157, South Africa

  • Teva Investigational Site 90099

    RECRUITING

    Bellville, 7530, South Africa

  • Teva Investigational Site 90100

    RECRUITING

    Wynberg, 2090, South Africa

  • Teva Investigational Site 90101

    RECRUITING

    Benoni, 1500, South Africa

  • Teva Investigational Site 90102

    RECRUITING

    Cape Town, 7570, South Africa

  • Teva Investigational Site 90105

    RECRUITING

    Pretoria, 204, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.